Petah Tikva

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Acute myeloid leukaemia1 trial
• Amyloidosis1 trial
• Childhood cancers1 trial
• Metastatic breast cancer1 trial

Phase

• Phase 33 trials

Status

• Recruiting3 trials

Lead sponsor

• Alnylam Pharmaceuticals1 trial
• Olema Pharmaceuticals, Inc.1 trial
• Syndax Pharmaceuticals1 trial

Running trials

• Recruiting

  Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation

  NCT07211958· Phase 3· Syndax Pharmaceuticals· Source

  Contact: Syndax Pharmaceuticals

• Recruiting

  Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

  NCT07085767· Phase 3· Olema Pharmaceuticals, Inc.· Source

  Contact: Olema Pharmaceuticals, Inc.

• Recruiting

  TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

  NCT07052903· Phase 3· Alnylam Pharmaceuticals· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Acute myeloid leukaemia1 recruiting
• Amyloidosis1 recruiting
• Childhood cancers1 recruiting
• Metastatic breast cancer1 recruiting